Early Small (cT1N0) Triple Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Early Small (cT1N0) Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) (NCT05215106) | Gustave Roussy, Cancer Campus, Grand Paris | 2021-12-06 |
Track Early Small (cT1N0) Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.